Clinical Trial Update: Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated a monoclonal antibody and vaccine therapy in patients with stage III or stage IV melanoma that had been surgically removed, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Intraocular Melanoma

Drugs mentioned

• Unspecified monoclonal antibody and vaccine therapy

Snippet

Sponsor: University of Southern California | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 1 | Status: COMPLETED